Deadline March 14, 2019 -- ASA Urges You to Submit Your Comments to FDA for International Rescheduling of Cannabis
The Food and Drug Administration (FDA) is collecting comments from you to help the United States shape its position on rescheduling cannabis during an upcoming United Nations meeting. The deadline for submissions is 11:59 p.m. on March 14, 2019. To make a comment, please click here. If you choose to submit a PDF, please make sure you reference FDA-2019-N-0767 in your comments.
These comments will directly impact how the United States responds to the World Health Organization’s recent recommendation regarding the rescheduling of cannabis under international law. Specifically, the World Health Organization is recommending that cannabis and cannabis resin be removed from Schedule IV of the 1961 Single Convention on Narcotic Drugs and that THC and its isomers be moved from the 1971 Convention on Psychotropic Substances to join cannabis in Schedule I of the Single Convention.
Schedule IV is the most restrictive classification for substances controlled under international treaties. It is reserved for substances that have the characteristics of being liable to abuse, produce ill effects, and are not suitable for medical treatment. Removing cannabis from Schedule IV of the Single Convention will signal that the international community recognizes the medicinal potential of cannabis and its derivatives.
Please take some time to make your voices heard through the Federal Register today!
Share this page